• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronavirus Disease 2019 Sepsis: A Nudge Toward Antibiotic Stewardship.

作者信息

Coz Yataco Angel O, Simpson Steven Q

机构信息

University of Kentucky College of Medicine and the Lexington Veterans Affairs Medical Center, Lexington, KY.

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, Lawrence, KS.

出版信息

Chest. 2020 Nov;158(5):1833-1834. doi: 10.1016/j.chest.2020.07.023. Epub 2020 Jul 21.

DOI:10.1016/j.chest.2020.07.023
PMID:32707181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7373061/
Abstract
摘要

相似文献

1
Coronavirus Disease 2019 Sepsis: A Nudge Toward Antibiotic Stewardship.2019冠状病毒病脓毒症：推动抗生素合理使用
Chest. 2020 Nov;158(5):1833-1834. doi: 10.1016/j.chest.2020.07.023. Epub 2020 Jul 21.
2
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗？
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
3
Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter.一家地处新冠疫情早期震中之外的医院的抗生素使用与管理
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.01011-20.
4
Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program's prospective review.将新冠病毒疾病（COVID-19）患者标识实际应用于抗菌药物管理计划的前瞻性审查。
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1108-1110. doi: 10.1017/ice.2020.133. Epub 2020 Apr 15.
5
COVID-19 will further exacerbate global antimicrobial resistance.新型冠状病毒肺炎将进一步加剧全球抗菌药物耐药性。
J Travel Med. 2020 Sep 26;27(6). doi: 10.1093/jtm/taaa098.
6
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
7
Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.降钙素原作为重症监护病房中新冠肺炎患者抗生素管理工具的应用
J Glob Antimicrob Resist. 2020 Sep;22:782-784. doi: 10.1016/j.jgar.2020.07.017. Epub 2020 Jul 25.
8
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.降低2019新型冠状病毒所致死亡率：宿主导向疗法应成为一种选择。
Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.
9
Outcome of non-invasive ventilation in COVID-19 critically ill patients: A Retrospective observational Study.新型冠状病毒肺炎危重症患者无创通气的结局：一项回顾性观察研究
Anaesth Crit Care Pain Med. 2020 Oct;39(5):579-580. doi: 10.1016/j.accpm.2020.07.012. Epub 2020 Jul 28.
10
COVID-19 and end of life.新冠病毒肺炎与生命终末期
Br J Community Nurs. 2020 Aug 2;25(8):414. doi: 10.12968/bjcn.2020.25.8.414.

引用本文的文献

1
The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染在促发异常免疫反应和脓毒症中的作用：SARS-CoV-2相关脓毒症与其他原因所致脓毒症的比较
Infect Med (Beijing). 2023 Apr 28;2(3):202-211. doi: 10.1016/j.imj.2023.04.006. eCollection 2023 Sep.
2
Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease.谷胱甘肽缺乏在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染发病机制中的作用及其对重症2019冠状病毒病（COVID-19）宿主免疫反应的影响
Front Microbiol. 2022 Oct 6;13:979719. doi: 10.3389/fmicb.2022.979719. eCollection 2022.
3
Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins.全基因组测序揭示孟加拉国分离株中SARS-CoV-2基因组的点突变及其对病毒蛋白的结构影响。
RSC Adv. 2021 Dec 3;11(61):38868-38879. doi: 10.1039/d1ra05327b. eCollection 2021 Nov 29.
4
Sepsis triggered oxidative stress-inflammatory axis: the pathobiology of reprogramming in the normal sleep-wake cycle.脓毒症引发氧化应激-炎症轴：正常睡眠-觉醒周期中重编程的病理生物学。
Mol Cell Biochem. 2022 Sep;477(9):2203-2211. doi: 10.1007/s11010-022-04432-1. Epub 2022 Apr 22.
5
Circulating Microvesicle-Associated Inducible Nitric Oxide Synthase Is a Novel Therapeutic Target to Treat Sepsis: Current Status and Future Considerations.循环微泡相关诱导型一氧化氮合酶是治疗脓毒症的一种新的治疗靶点：现状与未来展望。
Int J Mol Sci. 2021 Dec 13;22(24):13371. doi: 10.3390/ijms222413371.
6
High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19.高 CD4/CD8 比值可识别出易感染 COVID-19 致死的高危人群。
Scand J Immunol. 2022 Mar;95(3):e13125. doi: 10.1111/sji.13125. Epub 2021 Dec 13.
7
Predicting mortality in SARS-COV-2 (COVID-19) positive patients in the inpatient setting using a novel deep neural network.利用新型深度神经网络预测住院 SARS-COV-2（COVID-19）阳性患者的死亡率。
Int J Med Inform. 2021 Oct;154:104556. doi: 10.1016/j.ijmedinf.2021.104556. Epub 2021 Aug 21.
8
Flavonoids are promising safe therapy against COVID-19.类黄酮是对抗新冠病毒的一种很有前景的安全疗法。
Phytochem Rev. 2022;21(1):291-312. doi: 10.1007/s11101-021-09759-z. Epub 2021 May 22.
9
Severe COVID-19 in the intensive care unit: a case series.重症监护室中的严重 COVID-19：病例系列。
J Med Case Rep. 2021 May 3;15(1):259. doi: 10.1186/s13256-021-02799-1.
10
Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19.新型冠状病毒肺炎患者中中肾上腺髓质原肽的临床实用性。
Lab Med. 2021 Sep 1;52(5):493-498. doi: 10.1093/labmed/lmab032.

本文引用的文献

1
Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers.美国疾病控制与预防中心《2019年一线医疗服务提供者抗生素耐药性威胁报告》的关键要点
Crit Care Med. 2020 Jul;48(7):939-945. doi: 10.1097/CCM.0000000000004371.
2
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients.严重脓毒症患者初始抗菌药物给药时间延长与进展为感染性休克相关。
Crit Care Med. 2017 Apr;45(4):623-629. doi: 10.1097/CCM.0000000000002262.
3
Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.不恰当的抗菌治疗会导致人类感染性休克的生存率降低五倍。
Chest. 2009 Nov;136(5):1237-1248. doi: 10.1378/chest.09-0087. Epub 2009 Aug 20.